• 제목/요약/키워드: reaction pathway

검색결과 544건 처리시간 0.03초

Oleuropein Induces Apoptosis Via the p53 Pathway in Breast Cancer Cells

  • Hassan, Zeinab Korany;Elamin, Maha Hussein;Omer, Sawsan Ali;Daghestani, Maha Hassan;Al-Olayan, Ebtesam Salah;Elobeid, Mai AbdelRahman;Virk, Promy
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권11호
    • /
    • pp.6739-6742
    • /
    • 2013
  • Background: Breast cancer is a major health problem worldwide. Olive oil induces apoptosis in some cancer cells due to phenolic compounds like oleuropein. Although oleuropein has anticancer activity, the underlying mechanisms of action remain unknown. The study aimed to assess the mechanism of oleuropin-induced breast cancer cell apoptosis. Materials and Methods: p53, Bcl-2 and Bax gene expression was evaluated by semi-quantitative reverse transcriptase polymerase chain reaction (RT-PCR) in luminal MCF-7 cells. Results: Oleuropein-induced apoptosis was accompanied by up-regulation of both p53 and Bax gene expression levels and down-regulation in Bcl2. Conclusions: Oleuropein induces apoptosis in breast tumour cells via a p53-dependent pathway mediated by Bax and Bcl2 genes. Therefore, oleuropein may have therapeutic potential in breast cancer patients by inducing apoptosis via activation of the p53 pathway.

2-Methoxy-1,4-naphthoquinone (MNQ) regulates cancer key genes of MAPK, PI3K, and NF-κB pathways in Raji cells

  • Wong, Teck Yew;Menaga, Subramaniam;Huang, Chi-Ying F.;Ho, Siong Hock Anthony;Gan, Seng Chiew;Lim, Yang Mooi
    • Genomics & Informatics
    • /
    • 제20권1호
    • /
    • pp.7.1-7.13
    • /
    • 2022
  • 2-Methoxy-1,4-naphthoquinone (MNQ) has been shown to cause cytotoxic towards various cancer cell lines. This study is designed to investigate the regulatory effect of MNQ on the key cancer genes in mitogen-activated protein kinase, phosphoinositide 3-kinase, and nuclear factor κB signaling pathways. The expression levels of the genes were compared at different time point using polymerase chain reaction arrays and Ingenuity Pathway Analysis was performed to identify gene networks that are most significant to key cancer genes. A total of 43 differentially expressed genes were identified with 21 up-regulated and 22 down-regulated genes. Up-regulated genes were involved in apoptosis, cell cycle and act as tumor suppressor while down-regulated genes were involved in anti-apoptosis, angiogenesis, cell cycle and act as transcription factor as well as proto-oncogenes. MNQ exhibited multiple regulatory effects on the cancer key genes that targeting at cell proliferation, cell differentiation, cell transformation, apoptosis, reduce inflammatory responses, inhibits angiogenesis and metastasis.

자궁적출술 환자를 위한 critical pathway 개발과 적용효과 (Critical Pathway Development for the Hysterectomy Patients and its applied Effect)

  • 노기옥;박경숙
    • 여성건강간호학회지
    • /
    • 제6권2호
    • /
    • pp.234-257
    • /
    • 2000
  • At present in the medical care, the study and effort for producing health service to consider efficiency, effectiveness, and quality are urgently called for because of the difficulty in the keen competition according to the inter- nationalization and opening, the operation in the medical institution service testing system, the change in the medical policy of KDRGs, and the lack of the health care cost increasing rate. As an alternative, the case management for the new management system is introduced in the U.S., and the Critical Pathway that is the method designing the contents of activity and its result has been developed and applied in order to anticipate and manage the patient-outcome for the realization of the cost-effective case-management. Thus, this study intended to analyze the effectiveness to obtain by developing the Critical Pathway presented as the method to improve the quality-betterment and cost effectiveness through the continuous and consistent patient management for the hysterectomy patient and applying it to the real practice. As a study method, this author formed a conceptual framework through considering five Critical Pathway used in the current U.S. and three Critical Pathway presented in the literature to develop the Critical Pathway for the hysterectomy patient, and made out the preliminary Critical Pathway through reviewing the old chart. This author made the verified the validity of the expert group about the developed Critical Pathway, and to confirm the possibility of practice application, completed and settled the final Critical Pathway after using the Critical Pathway to the hysterectomy patient from March 1st to 15th, 1997. Finally, to analyze the application-effect of the developed Critical Pathway, this author offered health care service applying the Critical Pathway to the hysterectomy patient from April 15th to August 31th, 1997. The guide for the Critical Pathway was carried out in advance by outpatient setting nurse for outpatient setting visit before the operation, and after hospitalization the primary nurse monitored the execution degree on the every duty. After discharge this author surveyed the complication through phone visiting, and one month after discharge surveyed the patient's reaction about the offered service when outpatient setting visit and analyzed the result. The source for health care cost was obtained by the statistics about the hospital charge which was offered by the General Business Department. The results were as follows. 1. It was decided that the vertical line of the Critical Pathway was made up of eight items such as monitoring/assessment, treatment, line/drains, activity, medication, lab test, diet, patient teaching, and the horizontal line of the Critical Pathway was made up of from hospitalization to discharge. 2. After the analysis of service contents through reviewing the old chart, it was decided that the horizontal line of the preliminary Critical Pathway was made up of from hopitalization to fourth postoperative day, and the vertical line of it was divided into eight items which were the contents to occur with the time frame of the horizontal line. 3. After the verifying the validity of the expert group about the preliminary Critical Pathway, the horizontal line was amended from hopitalization to third postoperative day, and taking their consensus, some contents of the horizontal line was amended and deleted. 4. From March 1st to 15th, 1997, to confirm the clinical suitability, this author offered eight hysterectomy patients the medical service through the Critical Pathway. The result was that three of them could be discharged at the expected discharge day, and the others later than that day. Supplementing the preliminary Critical Pathway through analyzing the cause of that delay- case, this author developed the final Critical Pathway. 5. There were no significant differences between the experimental and the control group in the incidence of complication(P > 0.05). 6. The 92.4% of experimental group was satisfied with the Critical Pathway service. 7. The length of hospital stay of the experimental group offered with the Critical Pathway service was 4.6 days and there was a significant difference that it was 1.3 days shorter than that of the control group(t=-29.514, P=0.000). 8. There wsa a significant difference that the mean medical charge per one patient of the experimental group offered the Critical Pathway service was cheaper \124,150 than that of the control group(t=-9.826, P=0.000). 9. The result that the author assumed and analyzed hospital income with the rate of turning bed was assumed that the increase of hospital income was \63,245,072 for that study, and the income increase was expected with \68,704,864 for a year. The result that this author applied the Critical Pathway to the hysterectomy patient have no differences in the incidence of complication, high satisfaction with that service, and the length of hospital stay decreased in the experimental group, and the mean hospital charge per one patient decreased, but hospital income increased. Suggestions for further study and nursing practice are as follows. 1. The study to apply the Critical Pathway for a year, verify the validity, and measure the effect repeatedly is needed. 2. To apply and manage the Critical Pathway effectively, the study to computerize it is needed. 3. The study to develop hospital-based Critical Pathway about other diseases or procedure, and measure the effect is needed.

  • PDF

The Dose Dependent Effects of Ruxolitinib on the Invasion and Tumorigenesis in Gliomas Cells via Inhibition of Interferon Gamma-Depended JAK/STAT Signaling Pathway

  • Delen, Emre;Doganlar, Oguzhan
    • Journal of Korean Neurosurgical Society
    • /
    • 제63권4호
    • /
    • pp.444-454
    • /
    • 2020
  • Objective : Glioblastoma multiforme (GBM) is the most aggressive for of brain tumor and treatment often fails due to the invasion of tumor cells into neighboring healthy brain tissues. Activation of the Janus kinase-signal transducer and activator of transcription (JAK/STAT) signaling pathway is essential for normal cellular function including angiogenesis, and has been proposed to have a pivotal role in glioma invasion. This study aimed to determine the dose-dependent effects of ruxolitinib, an inhibitor of JAK, on the interferon (IFN)-I/IFN-α/IFN-β receptor/STAT and IFN-γ/IFN-γ receptor/STAT1 axes of the IFN-receptor-dependent JAK/STAT signaling pathway in glioblastoma invasion and tumorigenesis in U87 glioblastoma tumor spheroids. Methods : We administered three different doses of ruxolitinib (50, 100, and 200 nM) to human U87 glioblastoma spheroids and analyzed the gene expression profiles of IFNs receptors from the JAK/STAT pathway. To evaluate activation of this pathway, we quantified the phosphorylation of JAK and STAT proteins using Western blotting. Results : Quantitative real-time polymerase chain reaction analysis demonstrated that ruxolitinib led to upregulated of the IFN-α and IFN-γ while no change on the hypoxia-inducible factor-1α and vascular endothelial growth factor expression levels. Additionally, we showed that ruxolitinib inhibited phosphorylation of JAK/STAT proteins. The inhibition of IFNs dependent JAK/STAT signaling by ruxolitinib leads to decreases of the U87 cells invasiveness and tumorigenesis. We demonstrate that ruxolitinib may inhibit glioma invasion and tumorigenesis through inhibition of the IFN-induced JAK/STAT signaling pathway. Conclusion : Collectively, our results revealed that ruxolitinib may have therapeutic potential in glioblastomas, possibly by JAK/STAT signaling triggered by IFN-α and IFN-γ.

H2/CO 합성가스의 연소 특성에 관한 연구 (Study on Combustion Characteristics of H2/CO Synthetic Gas)

  • 김태권;박정;조한창
    • 한국환경과학회지
    • /
    • 제17권6호
    • /
    • pp.689-698
    • /
    • 2008
  • Numerical study is conducted to predict effects of radiative heat loss and fuel composition in synthetic gas diffusion flame diluted with $CO_2$. The existing reaction models in synthetic gas flames diluted with $CO_2$ are evaluated. Numerical simulations with and without gas radiation, based on an optical thin model, are also performed to concrete impacts on effects of radiative heat loss in flame characteristics. Importantly contributing reaction steps to heat release rate are compared for synthetic gas flames with and without $CO_2$ dilution. It is also addressed that the composition of synthetic gas mixtures and their radiative heat losses through the addition of $CO_2$ modify the reaction pathways of oxidation diluted with $CO_2$.

상호 확산 반응 중의 생성상 제어 (Product Phase Control During Interdiffusion Reactions)

  • 박준식;김지훈
    • 한국주조공학회지
    • /
    • 제26권1호
    • /
    • pp.27-33
    • /
    • 2006
  • Phase evolutions involving nucleation stages together with diffusional growth have been examined in order to provide a guideline for determining rate limiting stages during phase evolutions. In multiphase materials systems in coatings, composites or multilayered structures, diffusion treatments often result in the development of metastable/intermediate phases at the reaction interfaces. The development of metastable phases during solid state interdiffusion demonstrates that the nucleation reaction can be one controlling factor. Also, the concentration gradient and the relative magnitudes of the component diffusivities provide a basis for a phase selection and the application of a kinetic bias strategy in the phase selection. For multicomponent alloy systems, the identification of the operative diffusion pathway is central to control phase formation. Experimental access to the nucleation and growth stage is discussed in thin film multi layers and bulk samples.

Substitution Reaction of Fe(CO)$_5$ by Ethylene

  • Ko, Jae-Jung
    • Bulletin of the Korean Chemical Society
    • /
    • 제9권2호
    • /
    • pp.87-94
    • /
    • 1988
  • The substitution reaction of Fe$(CO)_5$ by ethylene has been studied for plausible intermediates by means of extended Huckel calculations. Among various reaction mechanisms the favorable reaction pathway is via a dissociative mechanism in which ethylene approaches to Fe$(CO)_4$ unit. For Fe$(CO)_4$ fragment, the square planar conformation is found to be the most stable form by the extended Huckel calculations. Our calculations show that ethylene attacks square planar intermediate formed by removing one carbonyl from Fe$(CO)_5$ and then the unstable species thus formed is distored to the most stable trigonal bipyramid with the ethylene lying in the equatorial plane.

PM3 Studies on the Acid-Catalyzed Hydrolysis of 1-Phenoxyethyl Propionate

  • 김찬경;이인영;정동수;이본수;이익춘
    • Bulletin of the Korean Chemical Society
    • /
    • 제19권9호
    • /
    • pp.993-999
    • /
    • 1998
  • Acid catalyzed hydrolysis of 1-phenoxyethyl propionate, Ⅰ, has been studied using the PM3 method in the gas phase. The first step of the reaction is the protonation of basic sites, three different oxygens in Ⅰ, producing three protonated species Ⅱ, Ⅲ and Ⅳ. All possible reaction pathways have been studied from each protonated structure. Changes in the reaction mechanisms have also been discussed from the results obtained by varying a nucleophile from a water monomer to a water dimer to a complex between one water molecule and an intermediate product (propionic acid or phenol) produced in the preceding unimolecular dissociation processes. Minimum energy reaction pathway is 2-W among the possible pathways, in which water dimer acts as an active catalyst and therefore facilitates the formation of a six-membered cyclic transition state. Lower barrier of 2-W is ascribed to an efficient bifunctional catalytic effect of water molecules. PM3-SM3.1 single point calculations have been done at the gas-phase optimized structure (SM3.1/PM3//PM3) to compare theoretical results to those of experimental work.

Substituent Effect in Photochemistry of Carbonyl Compounds: α-Halovalerophenones

  • Cho, Sung-Su;Park, Bong-Ser
    • Bulletin of the Korean Chemical Society
    • /
    • 제25권1호
    • /
    • pp.42-44
    • /
    • 2004
  • Valerophenones containing a substituent at alpha position to the carbonyl group show the remarkable substituent effects on their photochemical reactions. ${\alpha}$-Bromovalerophenone gives only the C-Br bond cleavage products, but the ${\alpha}$-chlorovalerophenone follows the classical Norrish/Yang reaction pathway predominantly.

이온성 액체 촉매를 이용한 Tetrahydrotricyclopentadiene의 이성화 반응 경로에 관한 연구 (A Study on the Reaction Pathway for Isomerization of Tetrahydrotricyclopentadiene Using Ionic Liquid Catalyst)

  • 김대현;한정식;전종기;임진형
    • 공업화학
    • /
    • 제26권3호
    • /
    • pp.366-371
    • /
    • 2015
  • 루이스 산도가 다른 두 종류의 클로로알루미네이트계 이온성 액체(IL) 촉매를 사용하여 tetrahydrotricyclopentadiene (THTCPD) 이성화 반응 거동에 관하여 연구하였다. 루이스 산도가 낮은 1-butyl-3-methylimidazolun chloride $(BMIC)/AlCl_3$와 높은 pyridine hydrochloride $(PHC)/AlCl_3$계 IL 촉매를 이용하고 온도와 시간을 반응 인자로 하여 THTCPD의 이성화 반응 경로를 고찰하였다. IL 촉매의 루이스 산도 증가에 따라 THTCPD 이성화 전환율을 증가시킬 수 있었다. 반응온도 및 IL 촉매의 산도에 따라 THTCPD 이성화 반응경로가 바뀌었다. 산도가 낮은 $BMIC/AlCl_3$ IL 촉매의 경우에는 기존에 사용되어오던 $AlCl_3$ 촉매와 유사한 반응 경로를 보이지만, 반응온도가 높아짐에 따라 endo, exo, endo-(norbornene; NB) ${\rightarrow}$ exo, exo, endo-NB ${\rightarrow}$ diamondoid로의 골격 재배열화 반응이 일어났다. 하지만, 산도가 높은 $PHC/AlCl_3$ IL 촉매의 경우에는 $TEAC/AlCl_3$ IL 촉매와는 다른 새로운 두 가지 경로(endo, exo, endo-NB ${\rightarrow}$ exo, exo, endo- NB ${\rightarrow}$ exo, exo, exo-NB 및 endo, exo, endo-NB ${\rightarrow}$ exo, exo, endo-NB ${\rightarrow}$ exo, exo, exo-(cyclopentadiene; CP))가 추가로 관찰되었다.